Skip to Content
VirusesViruses
  • Communication
  • Open Access

6 February 2014

9 Pages

Pretreatment of Mice with Oligonucleotide prop5 Protects Them from Influenza Virus Infections

,
,
,
,
,
and
1
Beijing University of Technology, No.100, Pingleyuan, Chaoyang District, Beijing 100124, China
2
Beijing Institute of Radiation Medicine, No.27, Taiping Road, Haidian District, Beijing 100850, China
3
Henan University of Traditional Chinese Medicine, No.1 Jinshui Road, Zhengzhou, Henan 450008, China
*
Author to whom correspondence should be addressed.
This article belongs to the Section Viral Immunology, Vaccines, and Antivirals

Abstract

Influenza A virus is a successful parasite and requires host factors to complete its life cycle. Prop5 is an antisense oligonucleotide, targeting programmed cell death protein 5 (PDCD5). In this study, we tested the antiviral activity of prop5 against mouse-adapted A/FM/1/47 strain of influenza A virus in a mouse model. Prop5 intranasally administered the mice at dosages of 10 and 20 mg/kg/d at 24 h and 30 min before infection, provided 80% and 100% survival rates and prolonged mean survival days in comparison with influenza virus-infected mice (both p < 0.01). Moreover, viral titres in mice pretreated with prop5, at dose of 10 and 20 mg/kg/d, had declined significantly on day two, four, and six post-infection compared with the yields in infected mice (p < 0.05 or p < 0.01); lung index in mice pretreated with prop5 (20 mg/kg/d) had been inhibited on day six post-infection (p < 0.05). Western blotting and immunohistochemistry showed that prop5 could down-regulate the PDCD5 protein expression levels in lung tissues of infected mice. These data indicate that antisense oligonucleotide prop5 is a promising drug for prophylaxis and control influenza virus infections and provides an insight into the host-pathogen interaction.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.